Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7.41% is 32% above its 5-year average of -10.96%, near the high end of its 5-year range (-34.78%–2.11%).
0.26% above its 12-month average of -7.43%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7.49%.
NET PROFIT MARGIN
-7.41%
NET PROFIT MARGIN AVG TTM
-7.43%
NET PROFIT MARGIN AVG 3Y
-13.40%
NET PROFIT MARGIN AVG 5Y
-10.96%
NET PROFIT MARGIN AVG 10Y
-7.42%
NET PROFIT MARGIN AVG 15Y
-3.42%
NET PROFIT MARGIN AVG 20Y
-1.47%
CURRENT VS TTM AVG
+0.26%
CURRENT VS 3Y AVG
+44.68%
CURRENT VS 5Y AVG
+32.39%
CURRENT VS 10Y AVG
+0.12%
CURRENT VS 15Y AVG
-116.45%
CURRENT VS 20Y AVG
-405.49%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-2750.00%
vs the sector median at left
Orthofix Medical Inc.
Market Cap
$380.75M
Net Profit Margin
-7.41%
TTM Avg
-7.43%
3Y Avg
-13.40%
5Y Avg
-10.96%
Market Cap
$381.49M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$420.03M
Net Profit Margin
-1392.61%
TTM Avg
-834.59%
3Y Avg
-416.33%
5Y Avg
-277.55%
Market Cap
$375.76M
Net Profit Margin
-81.04%
TTM Avg
-157.37%
3Y Avg
-379.90%
5Y Avg
-317.33%
Market Cap
$386.69M
Net Profit Margin
-112.58%
TTM Avg
-193.15%
3Y Avg
-231.74%
5Y Avg
-161.96%
Market Cap
$373.48M
Net Profit Margin
-391.90%
TTM Avg
-78.17%
3Y Avg
-42.66%
5Y Avg
-429.16%
Market Cap
$372.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$398.17M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$401.52M
Net Profit Margin
-57.42%
TTM Avg
-73.98%
3Y Avg
-95.04%
5Y Avg
-95.04%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $380.75M | -7.41% | -7.43% | -13.40% | -10.96% |
| Zura Bio Limited (ZURA)vs › | $381.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| YD Bio Limited Ordinary Shares (YDES)vs › | $420.03M | -1392.61% | -834.59% | -416.33% | -277.55% |
| Canopy Growth Corporation (CGC)vs › | $375.76M | -81.04% | -157.37% | -379.90% | -317.33% |
| REGENXBIO Inc. (RGNX)vs › | $386.69M | -112.58% | -193.15% | -231.74% | -161.96% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $373.48M | -391.90% | -78.17% | -42.66% | -429.16% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $372.98M | 0.00% | 0.00% | -102.82% | -175.43% |
| Shoulder Innovations, Inc. (SI)vs › | $398.17M | -58.33% | -67.34% | -66.78% | -66.78% |
| Carlsmed, Inc. (CARL)vs › | $401.52M | -57.42% | -73.98% | -95.04% | -95.04% |
| Opus Genetics, Inc. (IRD)vs › | $360.40M | -1091.82% | -436.37% | -220.06% | -1750.93% |
Operating Margin
-3.0%
Net Profit Margin
-7.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -7.49% |
| 2026-03-31 | -10.63% |
| 2025-12-31 | -1.01% |
| 2025-09-30 | -11.09% |
| 2025-06-30 | -6.93% |
| 2025-03-31 | -27.42% |
| 2024-12-31 | -13.51% |
| 2024-09-30 | -13.93% |
| 2024-06-30 | -16.84% |
| 2024-03-31 | -19.10% |
| 2023-12-31 | -11.06% |
| 2023-09-30 | -15.68% |
| 2023-06-30 | -21.08% |
| 2023-03-31 | -34.78% |
| 2022-12-31 | -5.78% |
| 2022-09-30 | -9.40% |
| 2022-06-30 | 2.11% |
| 2022-03-31 | -4.19% |
| 2021-12-31 | -26.24% |
| 2021-09-30 | -1.93% |
| 2021-06-30 | 1.99% |
| 2021-03-31 | -5.51% |
| 2020-12-31 | -7.97% |
| 2020-09-30 | 4.19% |
| 2020-06-30 | -25.19% |
| 2020-03-31 | 24.48% |
| 2019-12-31 | 9.62% |
| 2019-09-30 | -35.68% |
| 2019-06-30 | -0.47% |
| 2019-03-31 | 0.82% |
| 2018-12-31 | 7.33% |
| 2018-09-30 | -1.08% |
| 2018-06-30 | 0.83% |
| 2018-03-31 | 4.81% |
| 2017-12-31 | 1.34% |
| 2017-09-30 | 3.28% |
| 2017-06-30 | 3.54% |
| 2017-03-31 | -2.58% |
| 2016-12-31 | -2.98% |
| 2016-09-30 | 10.05% |
| 2016-06-30 | -7.10% |
| 2016-03-31 | 3.95% |
| 2015-12-31 | 3.22% |
| 2015-09-30 | -1.36% |
| 2015-06-30 | 3.54% |
| 2015-03-31 | -9.33% |
| 2014-12-31 | -5.78% |
| 2014-09-30 | 0.45% |
| 2014-06-30 | -0.68% |
| 2014-03-31 | -0.77% |
| 2013-12-31 | -10.21% |
| 2013-09-30 | -21.37% |
| 2013-06-30 | -2.36% |
| 2013-03-31 | 2.11% |
| 2012-12-31 | 18.31% |
| 2012-09-30 | 6.59% |
| 2012-06-30 | 9.38% |
| 2012-03-31 | 8.39% |
| 2011-12-31 | 8.18% |
| 2011-09-30 | 8.55% |
| 2011-06-30 | 6.94% |
| 2011-03-31 | -25.73% |
| 2010-12-31 | 5.54% |
| 2010-09-30 | 6.13% |
| 2010-06-30 | 7.16% |
| 2010-03-31 | 12.60% |
| 2009-12-31 | 6.57% |
| 2009-09-30 | 4.58% |
| 2009-06-30 | 4.32% |
| 2009-03-31 | 2.23% |
| 2008-12-31 | -0.54% |
| 2008-09-30 | -183.49% |
| 2008-06-30 | 4.47% |
| 2008-03-31 | 2.82% |
| 2007-12-31 | -8.16% |
| 2007-09-30 | 6.63% |
| 2007-06-30 | 5.83% |
| 2007-03-31 | 5.35% |
| 2006-12-31 | 6.37% |
| 2006-09-30 | -42.48% |
| 2006-06-30 | 15.02% |
| 2006-03-31 | 10.17% |
| 2005-12-31 | 8.97% |
| 2005-09-30 | 60.70% |
| 2005-06-30 | 11.82% |
| 2005-03-31 | 13.87% |
| 2004-12-31 | 12.92% |
| 2004-09-30 | 11.77% |
| 2004-06-30 | 11.12% |
| 2004-03-31 | 11.80% |
| 2003-12-31 | 12.98% |
| 2003-09-30 | 10.62% |
| 2003-06-30 | 12.60% |
| 2003-03-31 | 12.36% |
| 2002-12-31 | 14.33% |
| 2002-09-30 | 13.41% |
